Nilvadipine
Top View
- Identifying Mutations in Epilepsy Genes Impact on Treatment Selection
- Known Bioactive Library: Selleck Bioactive 10Mm, 3.33Mm, 1.11Mm
- Medication-Related Inpatient Falls: a Critical Review
- Drug Class Review on Calcium Channel Blockers
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Download Product Insert (PDF)
- Effects of Nilvadipine on Cerebral Blood Flow in Patients with Alzheimer Disease a Randomized Trial
- United States Patent (19) 11 Patent Number: 5,834,496 Young (45) Date of Patent: Nov
- What Kinds of Patients Requires Prophylactic Therapy?
- Lorazepam Losartan Potassium Loxoprofen Sodium Hydrate
- A Quantitative Structure – Toxicity Relationship of Drugs on Rat Summary
- Differential Effects of Antihypertensive Drugs with Differing Pharmacological Properties on the Basal Ambulatory Blood Pressure
- Prediction of Human Systemic, Biologically Relevant Pharmacokinetic Properties Based on Physicochemical Properties of Calcium Channel Blockers
- Autophagy Stimulation As a Promising Approach in Treatment of Neurodegenerative Diseases
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Solubility/Bioavailability Enhancement and Modified Release Formulations of Poorly Water-Soluble Drugs
- Drug Class Review on Calcium Channel Blockers
- Amlodipine - a Third Generation Dihydropyridine Calcium Antagonist